Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1886-1888

  Al Ali, Amein K ^a   Al Muhana, Fahad A ^a   Larbi, Emmanuel B ^a   Abdulmohsen, Mohammed F ^a   Al Sultan, Ali I ^a   Al Maden, Mohamed S ^a   Al Ateeq, Suad A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; GENDER; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYBRIDIZATION; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SAUDI ARABIA;

ADULT; AGE DISTRIBUTION; AGED; ALLELES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SAUDI ARABIA; SEX DISTRIBUTION;

EID: 31844439525     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. NHLBI morbidity and mortality chartbook, 2002. Bethesda (MD): National Heart, Lung and Blood Instit. May 2002. Available from URL: http://www.nhlbi.nih.gov/resources/cht-book
2. American Heart Association. International Cardiovascular Disease Statistic. USA: American Heart Organization; 2002.
3. Brass LM, Shaker LA. Family history in patients with transient ischemic attacks. Stroke 1991; 22: 837-872.
4. Nabel EG. Cardiovascular disease. N Engl J Med 2003; 349: 60-72.
5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
6. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545.
7. Nygard O, Vollset SE, Refsum H, Brattstorm L, Veland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999; 246: 425-454.
8. Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia an emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 1996; 106: 709-722.
9. Prattstorm L, Wilcken DEL, Ohrvik J, Brudin L. The common MTHFR gene mutation leads to hyperhomocysteinemia but not to vascular disease-the results of meta-analysis. Circulation 1998; 98: 2520-2526.
10. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M. Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 1996; 121: 293-294.
11. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase as a risk factor for coronary artery disease. Circulation 1997; 95: 2032-2036.
12. Ou T, Yamakawa-Kobayashi K, Arinami T, Ameniya H, Fujiwara H, Kawata K, et al. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphism are independent risk factors for coronary heart disease in Japanese: a case control study. Atherosclerosis 1998; 137: 23-28.
13. Scholtz CL, Odendaal HJ, Thiart R, Loubser L, Hillermann R, Delport R, et al. Analysis of two mutations in the MTHFR gene associated with mild hyperhomocysteinemia-heterogeneous distribution in the South African population. S Afr Med J 2002; 92: 464-467.
14. Al-Nuaim AR. High prevalence of metabolic risk factors for CVD among Saudi population, aged 30-64 years. Int J Cardiol 1997a; 19: 227-235.
15. Al-Nuaim AR. Serum total and fractionated cholesterol distribution and prevalence of hypercholesterolemia in urban and rural communities in Saudi Arabia. Int J Cardiol 1997; 58: 141-149.
16. Almawi WY. C677T and A1298C single nucleotide polymorphism in the methylenetetrahydrofolate reductase gene among Bahraini Arabs. Thromb Haemaost 2004; 91: 843-845.
17. Heux S, Morin F, Lea RA, Ovcaric M, Tajouri L, Griffiths LR. The methylenetetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res 2004; 27: 663-667.
18. Pollak RD, Friedlander Y, Polllak A, Idelso M, Bejarano A, Blumenfeld A. Ethnic differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase gene in healthy Israeli populations. Genet Test 2000; 4: 309-311.